Limitations of epidemiological and serologic studies addressing simian virus 40 and non-Hodgkin's lymphoma [1]

Cancer Investigation

Volumn 24, Issue 3, 2006, Pages 333-336

  Vilchez, Regis A ^a  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Lymphomas; NHL; SV40; T antigen

Indexed keywords

POLIOMYELITIS VACCINE; VIRUS DNA;

CARCINOGENESIS; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EVIDENCE BASED MEDICINE; HUMAN; LETTER; NONHODGKIN LYMPHOMA; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; SEROPREVALENCE; SIMIAN VIRUS 40; VIRUS INFECTION;

ANIMALS; DRUG CONTAMINATION; HUMANS; LYMPHOMA, NON-HODGKIN; POLIOVIRUS VACCINES; POLYOMAVIRUS INFECTIONS; SIMIAN VIRUS 40; TUMOR VIRUS INFECTIONS;

EID: 33646479324     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900600634161     Document Type: Letter

References (43)

1. Engels, E.A. Does simian virus 40 cause non-hodgkin's lymphoma? A review of the laboratory and epidemiological data. Cancer Invest. 2005, 23 (6), 529-536.
2. Stratton, K.; Almario, D.A.; McCormick, M.C. SV40 contamination of polio vaccine and cancer. Immunization Safety Review Committee, Board of Health Promotion and Disease Prevention, Institute of Medicine of the National Academies. The National Academies Press; Washington DC, 2003.
3. Rollison, D.E.; Shah, K.V. The epidemiology of SV40 infection due to contaminated polio vaccines: relation of the virus to human cancer. In: Khalili, K., Stoner, G.L., Eds. Human Polyomaviruses: Molecular and Clinical Perspectives (Wiley-Liss, Inc, New York 2001), 561-584.
4. Vilchez, R.A.; Kozinetz, C.A.; Butel, J.S. Conventional epidemiology and the link of SV40 infections with human cancers. Lancet Oncol. 2003, 4 (3), 188-191.
5. Vilchez, R.A.; Butel, J.S. Emergent human pathogen simian virus 40 and its role in cancer. Clin. Microbiol. Rev. 2004, 17 (3), 495-508.
6. Barbantini-Brodano, G.; Corallini A.; Acolla, R.S.; Martini, F.; Tognon, M. Lack of serologic evidence for prevalent simian virus 40 infection in humans. J. Natl. Cancer. Inst. 2004, 96 (10), 803-804.
7. Engels, E.A.; Rodman, L.H.; Frish, M.; Goedert, J.J.; Biggar, R.J. Childhood exposure to simian virus 40 contaminated poliovirus vaccine and risk of AIDS associated non-Hodgkin's lymphoma. Int. J. Cancer 2003, 106 (2), 283-287.
8. Engels, E.A.; Katki, H.A.; Nielsen, N.M.; Winther, J.F.; Hjalgrim, H.; Gjernis, F.; Rosenberg PS, Frish M. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J. Natl. Cancer. Inst. 2003, 95 (7), 532-539.
9. Engels, E.A.; Chen, J.; Viscidi, R.P.; Shah, K.V.; Daniel, R.W.; Chatterjee, N.; Klebanoff, M.A. Poliovirus vaccination during pregnancy maternal seroconversion to simian virus 40 and risk of childhood cancer. Am. J. Epidemiol. 2004, 160 (4), 306-316.
10. Rollison, D.E.; Page, W.F.; Crawford, H.; Gridley, G.; Wacholder, S.; Martin, J.; Miller, R.; Engels, E.A. Case control study of cancer among US army veterans exposed to simian virus 40 contaminated adevovirus vaccine. Am. J. Epidemiol. 2004, 160 (4), 317-324.
11. Thu, G.O.; Hem, L.Y.; Hansen, S.; Moller, B.; Norstein, J.; Nokleby, H.; Grotmol, T. Is there an association between SV40 contaminated polio vaccine and lymphoproliferative disorders? an age period cohort analysis on Norwegian data from 1953 to 1997. Int. J. Cancer. 2005, 10.1002/ijc.21603.
12. Fredericks, D.N.; Relman, D.A. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin. Microbiol. Rev. 1996, 9(1), 18-33.
13. Melnick, J.L.; Stinebaugh, S. Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine. Proc. Soc. Exp. Biol. Med. 1962, 109, 965-968.
14. Cutrone, R.; Lednicky, J.; Dunn, G.; Rizzo, P.; Bocchetta, M.; Chumakov, K.; et al. Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer. Res. 2005, 65 (22), 10273-10279.
15. Vilchez, R.A.; Brayton, C.; Wong, C.; Zanwar, P.; Killen, D.E.; et al. Differential ability of two simian virus 40 strains to induce malignancies in weanling hamsters. Virology. 2004, 330 (1), 168-177.
16. De Sanjose, S.; Shah, K.V.; Domingo-Domenech, E.; Engels, E.A.; De Sevilla, A.F.; et al. Lack of serological evidence for an association between simian virus 40 and lymphoma. Int. J. Cancer. 2003, 104 (4), 522-524.
17. Viscidi, R.P.; Rollison, D.E.M.; Viscidi, E.; Clayman, B.; Rubalcaba, E.; Daniel, R. Major E.O.; Shah, K.V. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin. Diagn. Lab. Immunol. 2003, 10 (2), 278-285.
18. Carter J.J.; Madeleine, M.M.; Wipf, G.C.; Garcea, R.L.; Pipkin, P.A.; Minor, P.O.; Galloway D.A. Lack of serologic evidence for prevalent simian virus 40 infection in humans. J. Natl. Cancer. Inst. 2003, 95 (20), 1522-1530.
19. Shah, K.V.; Galloway, D.A.; Knowles, W.A.; Viscidi, R.P. Simian virus 40 (SV40) and human cancer: a review of the serological data. Rev. Med. Virol. 2004, 14 (4), 231-239.
20. Engels, E.A.; Chen, J.; Viscidi, R.P.; Shah, K.V.; Daniel, R.W.; Chatterjee, N.; Klebanoff, M.A. Poliovirus vaccination during pregnancy, maternal seroconversion to simian virus 40, and risk of childhood cancer. Am. J. Epidemiol. 2004, 160 (4), 306-316.
21. Engels, E.A.; Viscidi, R.P.; Galloway, D.A.; Carter, J.J.; Cerhan, J.R.; et al. Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. J. Natl. Cancer Inst. 2004, 96 (18), 1368-74.
22. Rollison, D.E.; Helzlsouer, K.J.; Halsey, N.A.; Shah, K.V.; Viscidi, R.P. Markers of past infection with simian virus 40 (SV40) and risk of incident non-hodgkin's lymphoma in a Maryland cohort. Cancer Epidemiol Biomarkers Prev. 2005, 14 (6), 1448-1452.
23. Imperiale, M.J. The human polyomaviruses: an overview. In: Khalili K., Stoner G.L., eds. Human Polyomaviruses: Molecular and Clinical Perspectives. Wiley-Liss, Inc.: New York, 2001, 53-71.
24. Lundstig, A.; Eliasson, L.; Lehtinen, M.; Sasnauskas, K.; Koskela, P.; Dillner, J. Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles. J. Gen. Virol. 2005, 86 (6), 1703-1708.
25. Arrington, A.S.; Moore, M.S.; Butel, J.S. SV40-positive brain tumor in scientist with risk of laboratory exposure to the virus. Oncogene. 2004, 23 (12), 2231-2235.
26. Rizzo, P.; Carbone, M.; Fisher, S.G.; Matker, C.; Swinnen, L.J.; et al. Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest. 1999, 116 (Suppl 6), 470-73.
27. David, H.; Mendoza, S.; Konishi, T.; Miller, C.W. Simian virus 40 is present in human lymphomas and normal blood. Cancer. Lett. 2001, 162 (10), 57-64.
28. Vilchez, R.A.; Madden, C.R.; Kozinetz, C.A.; Halvorson, S.J.; White, Z.S.; et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet. 2002, 359 (9309), 817-823.
29. Vilchez, R.A.; Lednicky, J.A.; Halvorson, S.J.; White, Z.S.; Kozinetz, C.A.; Butel, J.S. Detection of polyomavirus simian virus 40 tumor antigen DNA in AIDS-related systemic non-Hodgkin lymphoma. J. Acquir. Immune. Defic. Syndr. 2002, 29 (2), 109-116.
30. Shivapurkar, N.; Harada, K.; Reddy, J.; Scheuermann, R.H.; Xu, Y.; McKenna, R.W.; Milchgrub, S.; Kroft, S.H.; Feng, Z.; Gazdar, A.F. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet. 2002, 359 (9309), 851-852.
31. Shivapurkar, N.; Takahashi. T.; Reddy, J.; Zheng, Y.; Stastny, V.; et al. Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes. Cancer. Res. 2004, 64, 3757-3760.
32. Samaniego, F.; Wang, S.; Young, D.; Wang, S. Large T antigen DNA and protein of simian virus 40 in non-Hodgkin's lymphoma. (Abstract #4762). 95th Annual Meeting of the American Association for Cancer Research (March 27-31, 2004, Orlando, FL), 2004.
33. Vilchez, R.A.; Lopez-Terrada, D.; Finch, C.; Middleton, J.R.; Killen, D.E.; et al. Simian virus 40 tumor antigen expression and immunophenotypic profile of AIDS-related non-Hodgkin's lymphoma. Virology. 2005, 342 (1), 38-46.
34. Martini, F.; Dolcetti, R.; Gloghini, A.; Iaccheri, L.; Carbone, A.; Boiocchi, M.; Tognon, M. Simian-virus-40 footprints in human lymphoproliferative disorders of HIV" and HIV∧ patients. Int. J. Cancer. 1998, 78 (6), 669-674.
35. Nakatsuka S.-L; Liu, A.; Dong, Z.; Nomura, S.; Takakuwa, T.; Miyazato, H.; Aozasa, K. Simian virus 40 sequences in malignant lymphomas in Japan. Cancer. Res. 2003, 63 (22) 7606-7608.
36. Meneses, A.; Lopez-Terrada, D.; Zanwar, P.; Killen, D.E.; Monterroso, V.; Butel, J.S.; Vilchez, R.A. Lymphoproliferative disorders in Costa Rica and SV40. Haematologica. 2005, 90(12), 1635-1642.
37. Heinsohn, S.; Golta, S.; Kabisch, H.; zur Stadt, U. Standardized detection of Simian virus 40 by real-time quantitative polymerase chain reaction in pediatric malignancies. Haematologica. 2005, 90 (1), 95-100.
38. Daibata, M.; Nemoto, Y.; Kamioka, M.; Imai, S.; Taguchi, H. Simian virus 40 in Japanese patients with lymphoproliferative disorders. Br. J. Haematol. 2003, 121 (1), 190-191.
39. Capello, D.; Rossi, D.; Gaudino, G.; Carbone, A.; Gaidano, G. Simian virus 40 infection in lymphoproliferative disorders. Lancet. 2003, 361 (9351), 88-89.
40. MacKenzie, J.; Wilson, K.S.; Perry, J.; Gallagher, A.; Jarrett, R.F. Association between simian virus 40 DNA and lymphoma in the United Kingdom. J. Natl. Cancer Inst. 2003, 95 (13), 1001-1003.
41. Hernandez-Losa, J.; Fedele, C.G.; Pozo, F.; Tenorio, A.; Fernandez, V.; Castellvi, J.; Parada, C.; Ramon y Cajal, S. Lack of association of polyomavirus and herpesvirus types 6 and 7 in human lymphomas. Cancer 2005, 103 (2), 293-298.
42. Schuler, F.; Dolken, S.C.; Hirt, C.; Dolken, M.T.; Mentel, R.; Gurtler, L.G.; Dolken, G. No evidence for simain virus 40 DNA sequences in malignant non-Hodgkin's lymphoma. Int. J. Cancer 2006, 118 (2), 498-504.
43. Carbone, M.; Rdzanek, M.A.; Rudzinski, J.J.; De Marco, M.A.; Bocchetta, M.; Ramos Nino, M.; Mossman, B.; Pass, H.I. SV40 detection in human tumor specimens. Cancer. Res. 2005, 65 (21), 10120-10121.